3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
24
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
9
Myelodysplastic Syndromes
9
Stomach Neoplasms
8
Multiple Myeloma
7
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
6
Uterine Cervical Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Lung Neoplasms
5
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Melanoma
4
Leukemia, Monocytic, Acute
4
Head and Neck Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Carcinoma, Hepatocellular
4
Biliary Tract Neoplasms
4
Advanced Solid Tumour
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neuroendocrine Tumors
3
Mucositis
3
Leukemia, Myelomonocytic, Acute
3
Cholangiocarcinoma
3
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
3
Injections
2
pimonidazole
1
pembrolizumab
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Nitroglycerin
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Hydroxychloroquine
1
Drug Therapy
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Hypoxia
×
Injections
×
Clear all
NCT02233387
2019-03-08
HX4-cervix
Maastricht Radiation Oncology
Phase 2
Terminated
4 enrolled
NCT02584400
2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2
Terminated
1 enrolled